Advanced in Congenital Contractural Arachnodactyly

Hartmut H. Schmidt

Muenster, NW, DE 
Advanced in Congenital Contractural Arachnodactyly
Muenster, NW, DE 
OverviewLocationsClinical Research

Overview

Hartmut Schmidt practices in Muenster, Germany. Schmidt is rated as an Advanced expert by MediFind in the treatment of Congenital Contractural Arachnodactyly. Their top areas of expertise are Familial Transthyretin Amyloidosis, Primary Amyloidosis, Hepatocerebral Degeneration, Liver Transplant, and Endoscopy.

Their clinical research consists of co-authoring 252 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Congenital Contractural Arachnodactyly.

Locations

Muenster, NW, Germany
Other Locations
Leipzig, SN, Germany
Berlin, BE, Germany
Essen, NW, Germany
Dresden, SN 01069, Germany
Duisburg, NW, Germany
Halle, NI, Germany
Dippoldiswalde, SN 01744, Germany
Magdeburg, ST, Germany
Tuebingen, BW 72076, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome
A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome
Enrollment Status: Active_not_recruiting
Publish Date: October 10, 2025
A Phase II Study Evaluating Reduced Starting Dose and Dose Escalation of Cabozantinib as Second-line Therapy for Advanced HCC in Patients With Preserved Liver Function
A Phase II Study Evaluating Reduced Starting Dose and Dose Escalation of Cabozantinib as Second-line Therapy for Advanced HCC in Patients With Preserved Liver Function
Enrollment Status: Completed
Publish Date: January 30, 2025
Intervention Type: Drug
Study Drug: Cabozantinib Oral Tablet
Study Phase: Phase 2
A Randomized, Double Blind, Placebo-Controlled, Dose Titration, Phase 2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 494372 Administered Subcutaneously to Patients With High Lipoprotein(a)
A Randomized, Double Blind, Placebo-Controlled, Dose Titration, Phase 2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 494372 Administered Subcutaneously to Patients With High Lipoprotein(a)
Enrollment Status: Completed
Publish Date: December 20, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects With Alcohol-Induced Liver Decompensation (AILD)
A Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects With Alcohol-Induced Liver Decompensation (AILD)
Enrollment Status: Terminated
Publish Date: January 25, 2019
Intervention Type: Biological, Other
Study Phase: Phase 3
View 3 Less Clinical Trials

252 Total Publications

The intracellular Ca2+ sensitivity of transmitter release in glutamatergic neocortical boutons.
The intracellular Ca2+ sensitivity of transmitter release in glutamatergic neocortical boutons.
Journal: Science (New York, N.Y.)
Published: July 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Schmidt's expertise for a condition
ConditionClose
View All 14 Advanced Conditions
View All 43 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile